Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 29 September

Bell Direct
September 29, 2020

Morning Bell 28 September

Bell Direct
September 28, 2020

Weekly Wrap 25 September

Bell Direct
September 25, 2020

Morning Bell 24 September

Bell Direct
September 24, 2020

Morning Bell 23 September

Bell Direct
September 23, 2020

Morning bell 22 September

Bell Direct
September 22, 2020

Morning Bell 21 September

Bell Direct
September 21, 2020

Weekly Wrap 18 September

Bell Direct
September 18, 2020

Morning Bell 18 September

Bell Direct
September 18, 2020

Morning Bell 17 September

Bell Direct
September 17, 2020

Morning Bell 16 September

Bell Direct
September 16, 2020